The protease inhibitor TLCK alters the apparent molecular weights of some measles virus proteins by a mechanism unrelated to inhibition of proteolytic cleavage.
D000199:Actins; D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology*; D000818:Animals; D002460:Cell Line; D004591:Electrophoresis, Polyacrylamide Gel; D000882:Haplorhini; D008459:Measles virus / Q000032:analysis*; D008970:Molecular Weight; D011487:Protein Conformation / Q000187:drug effects; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology*; D014763:Viral Matrix Proteins; D014764:Viral Proteins
D000199:Actins; D000590:Amino Acid Chloromethyl Ketones; D014763:Viral Matrix Proteins; D014764:Viral Proteins; D014107:Tosyllysine Chloromethyl Ketone